White and Silver Floaters?

Related

• 

  Treatment Response to Antioxidant Supplementation Based on CFH and ARMS2Â Genetic Risk Allele Number in AREDS Patients With No AMD at Baseline

  Carl C. Awh, MD, FASRS

  Annual Meeting Talks

  2016

• 

  AMD Neovascular Expert Panel

  Robert L. Avery, MD

  Nizar S Abdelfattah, M.D.

  Nancy M. Holekamp, MD, FASRS

  Peter K. Kaiser, MD FASRS

  Pravin U. Dugel, MD

  Annual Meeting Talks

  2016

• 

  Vision Loss in a Patient With Primary Pulmonary Hypertension and Long-Term Use of Sildenafil

  Christina Y Weng, MD, MBA, FASRS

  Annual Meeting Talks

  2016